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Introduction
“Chicken pox is most commonly an annoying illness lasting three 
to seven days, and happily never seen again” (qtd. in Link 2005). 
This statement is by and large true about the actual chickenpox 
illness; in response to a chickenpox disease, the body builds immu-
nity against future occurrences, and rarely does a second case of 
chickenpox occur. However, the virus which caused the chicken-
pox may be seen again; it may resurface as a disease called shingles 
after years of lying dormant.
Chickenpox, the popular name for varicella, was a common child-
hood rash until the varicella vaccine was licensed for use in the 
United States in 1995. Prior to the introduction of the varicella 
vaccine, over 90% of Americans contracted chickenpox by age 
15 (Chickenpox 2013). Chickenpox symptoms typically last up 
to seven days (Simon 2012). However, even after recovery from 
chickenpox, the causative agent—varicella-zoster virus (VZV)—
remains dormant inside the body in sensory nerves. Reactivation 
of the virus later in life results in shingles, or herpes zoster, and 
presents differently than its predecessor. Chickenpox appears as 
an itchy rash and blisters all over the body, and shingles appears as 
a blistery rash restricted to one side of the body (Figures 1 and 
2). While chickenpox is generally considered a mild, unpleasant 
disease and is short lived, shingles is a more severe, painful disease 
which can have lasting effects. Generally, shingles symptoms clear 
in seven to ten days; however, it is not uncommon for it to take as 
long as a month to clear. The most common debilitating complica-
tion related to shingles is postherpetic neuralgia (PHN), defined as 
pain that persists longer than a month after the onset of shingles 
and lasts at least 90 days (Sampathkumar et al. 2009). The risk for 
PHN can reach 25-50% for shingles patients over the age of 50 
and up 75% for patients over the age of 70 (Giménez-Milà et al. 
2014). Other complications that may arise due to shingles include 
zoster ophthalmicus (reactivation of VZV in the trigeminal ganglia 
involving the ophthalmic division of the nerve, potentially damag-
ing the eye and surrounding structures), bacterial superinfections, 
and neurological  manifestations such as meningitis, encephalitis, 
myelitis, and complex regional pain syndromes I and II (Studahl et 
al. 2013 and Giménez-Milà et al. 2014).
Methods
In researching the background of varicella and herpes zoster, par-
ticularly theories regarding the reactivation of varicella-zoster 
virus, articles were gathered using various databases of scientific 
literature. These include PubMed,a service of the United States 
government, and various databases of health science journals 
made available through access to the Touro College and Ursuline 
College libraries.
Pathogenesis
Varicella zoster virus, the causative agent of varicella (or chicken-
pox), is a member of the herpesvirus family and alphaherpesvirus 
subclass. After the primary varicella infection, VZV withdraws to 
the dorsal root ganglia and trigeminal ganglia where it remains la-
tent. In fact, VZV in its latent stage can be found in multiple ganglia 
along the entire neuraxis (Liesegang 1999). It may remain dormant 
for the remainder of the life of its host, never causing any viral 
symptoms, or it may reactivate at any time as herpes zoster (HZ), 
more commonly known as shingles (Figure 3). However, according 
to Greg Bennett (qtd. in Polansky 2013), even during the latency 
period, which may last the entire lifetime of its host, VZV does not 
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remain inactive; transcription of the VZV has been 
detected even during this period. Reverse tran-
scription polymerase chain reaction has identi-
fied multiple VZV transcripts in latently infected 
human ganglia (Baird et al. 2013). “Thus,” claims 
Bennet, “the idea that the virus is inactive and 
presents no risk during the so-called inactive pe-
riod is a misconception. Rather, the latent viruses 
are active and can be dangerous.” 
The dermatological signs (i.e. rash and blisters) of 
herpes zoster are similar in their centripetal distri-
bution to dermatological signs of varicella (Figure 
4). This is suggestive that during primary varicella 
infection, the virus (VZV) spreads from infected 
skin cells to sensory nerve endings and then to the 
ganglia where it remains dormant. Subsequently, 
when VZV reactivates, it appears with the same 
centripetal distribution (Liesegang 1999). However, 
writes Liesegang, despite the similar dermatological 
distribution, it does not necessarily have to be so. It 
may be that the ganglia are directly infected hema-
togenously during the viremic phase of the initial 
varicella infection, and the path VZV takes when it 
reactivates as herpes zoster is simply indicative of 
the ganglia most exposed to reactivation stimuli. 
Figure 2: 
Shingles appears as a blistery rash restricted to one side of the body. Source: Shingles Pictures 2014
Figure 1: 
Chickenpox appears as an itchy rash and blisters 
all over the body. Source: Chickenpox Photos 
2013
Figure 3: 
The varicella zoster virus is the causative agent for chickenpox and shingles. After chickenpox, the virus 
never goes away. Instead, it settles in nerve cells and may reactivate years later, causing shingles, also 
called herpes zoster. Source: Smith 2014
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Epidemiology
Regardless of the path taken by VZV from initial varicella infection 
through latency and finally reactivation as herpes zoster, the cause 
of VZV reactivation remains unknown. There are numerous hy-
potheses as to what causes reactivation of VZV, although there is 
no concrete evidence supporting any one hypothesis and certainly 
no consensus among researchers. It is quite clear, however, that 
risk of herpes zoster increases with age. This is widely attributed 
to the decline of cell-mediated immunity (CMI) that progresses 
with aging. It is assumed that the dormant VZV is held in check 
by the cell-mediated immunity, not humoral immunity, so when 
CMI declines, the virus can flare up. Humoral immunity is assumed 
not to play a role in suppressing VZV, for herpes zoster has been 
shown to occur even in the presence of high levels of antibody 
titer, and antibody titer is a measure of humoral activity (Liesegang 
1999).
Genetic Correlation
Philip S. Rice (2011) suggests a genetic correlation as governing 
the latency and reactivation of herpes zoster virus. He hypothe-
sizes that exposure to the sun, or more particularly to ultra-violet 
radiation (UVR), plays a significant role in determining the gen-
otype of the VZV, and, thus, the virus has evolved into different 
genotypes based on climate. He builds his hypothesis on the fact 
that incidence of varicella is significantly lower in tropical regions 
than in temperate regions and that, even in temperate regions, 
varicella incidence is at its lowest in the summer. (In regions near 
the equator, i.e. tropical regions, the sun’s rays arrive almost per-
pendicular to them, thus higher levels of radiation. Near the poles, 
i.e. temperate regions, the angle of the sun’s rays spreads them out 
over a much greater area, providing less energy per unit of area 
(Raven et al. 2005).) He posits that in the tropics, the high levels of 
ultra-violet radiation may inactivate varicella virus in the vesicular 
fluid either before or after rupture of the vesicles. According to 
Asano et al. (1999), vesicular virus contributes more to the spread 
of the virus than the shedding of the virus from the respiratory 
tract. Consequently, in the tropics, transmission of varicella virus 
is significantly diminished due to ultra-violet radiation. As early 
humans lived in Africa—a tropical region— the virus evolved into 
a genotype resistant to ultra-violet radiation as a survival strate-
gy. When humankind spread to temperate regions, however, the 
virus shed its selective advantage of UVR resistance. However, as 
an evolutionary tradeoff for its lost advantage and, thus, reduced 
transmissibility (during the summer months when UVR is stron-
gest), the virus increased its propensity to reactivate as herpes 
zoster in order to ensure its continued survival in temperate re-
gions. Accordingly, the temperate genotype of VZV is prone to 
reactivation while the tropical genotype is not (except in severely 
immunosuppressed individuals). This explains why data of herpes 
zoster incidence in tropical countries is virtually absent. Rice, thus, 
suggests that the same mechanism responsible for UVR resistance 
in tropical VZV genotypes may also play a role in the latency and 
reactivation of temperate genotypes.
Quinlivan et al. (2013) also mention findings of various genotypes 
of VZV according to country. They write that VZV genotyping has 
identified five clades (a clade is a group consisting of an ancestor 
and all its descendants) of which clades 1 and 3 predominate in 
Europe, clade 2 in Japan, and clades 4 and 5 in Asia and Africa. 
Liesegang (1999) also notes the significant variation of VZV be-
tween tropical and temperate regions and insists that it must be 
due to agent specificity. 
A point one can take issue with and not addressed by Rice is that 
if the tropical genotype has acquired UVR resistance in order to 
avoid inactivation by ultra-violet radiation, then why is incidence 
of varicella lower in tropical regions than in temperate regions; 
shouldn’t the tropical genotype be able to thrive in constant sun-
light just as well as the temperate genotype does in decreased 
sunlight? The answer to this question may lie in that varicella is 
easily spread by respiratory route via airborne transmission, and 
this form of transmission is aided by winter weather. In addition 
to increased coughing during the winter months and the tenden-
cy to remain indoors due to the cold temperatures outside, the 
cold, wet weather may aid the survival of the virus outside a host 
(Zak-Prelich et al. 2002). In the tropics, despite the advantage of 
UVR resistance, the virus lacks the advantage of winter weather 
aiding in spreading it, and this may explain the lower incidence of 
Figure 4: 
The chickenpox rash exhibits centripetal distribution, meaning that the 
greatest concentration of lesions is on the trunk with fewer on distal 
extremities. This is in contrast to the smallpox rash which exhibits centrifugal 
distribution, meaning that the greatest concentration of lesions is on the face 
and extremities with fewer on the trunk. Source: Antipuesto 2008
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varicella there. Although, as Rice quoted from Asano et al. (1999), 
vesicular virus contributes more to spreading of the virus than 
does airborne transmission from the respiratory tract, and the 
tropics have the advantage of vesicular transmission even in pres-
ence of ultra-violet radiation, the lack of increased airborne trans-
mission may still be a viable explanation for the significantly lower 
incidence rate in the tropics.
Another setback to Rice’s hypothesis is a suggestion from 
Gallerani and Manfredini (2000) that ultra-violet radiation might 
be responsible for increased incidence of herpes zoster in the 
summer months (in temperate regions) due to its ability to sup-
press cellular immune response (Figure 5). When immunity to 
VZV is reduced, the latent virus is then able to reactivate as her-
pes zoster. This would suggest that ultra-violet radiation aids in 
virus activation, while Rice suggests that ultra-violet radiation is an 
inactivator of VZV. However, this is easily answered by the differ-
ent methods of activation in both diseases. Varicella is transmitted 
from person to person by vesicular route or respiratory route. 
Thus, because the virus in the vesicles (in the temperate geno-
type) is inactivated by ultra-violet radiation, spread of the virus 
is decreased. Herpes zoster, on the other hand, can only develop 
from reactivation of a latent VZV; it is never transmitted from one 
person to another (Simon 2012). Reactivation of the latent VZV 
is largely due to immunosuppression. Thus, ultra-violet radiation 
does not actually reactivate the virus, it merely suppresses the 
immunity that is keeping VZV dormant, and this allows VZV to 
reactivate. In other words, ultra-violet radiation may, in fact, inac-
tivate vesicular varicella virus as Rice posits, and the fact that ul-
tra-violet radiation is also responsible for increased herpes zoster 
incidence is not contradictory, because ultra-violet radiation does 
not actually activate herpes zoster.
While Rice suggests that genetic variations in the VZV itself result 
in prevalence or scarcity of VZV reactivation, others suggest that 
genetic variations in human subjects may be responsible. Schmader 
et al. (1998), in a study of communities in North Carolina over 
a six-year period, found significantly fewer herpes zoster cases 
among black subjects than among white subjects. To explain this 
phenomenon, they suggest that decline in cellular immunity due to 
aging may be less in black people than in white people, although 
they offer no explanation as to why. However Thomas and Hall 
(2004) take a novel approach in explaining why this may be so. 
They suggest that a less significant decline in cellular immunity 
among aging black subjects may be due to differential survival, 
or natural selection. “In populations with higher mortality rates, 
those who survive to old age may have robust immune systems 
(and therefore lower susceptibility to zoster),” they write. (They 
may be referring to the high mortality rate of even young children 
in Africa. They may also be referring to the increased mortality 
rate, even in the US, among African American children [Infant 
Mortality and African Americans 2013] Another approach Thomas 
and Hall take is that it may be caused by genetics; genetic differ-
ences between black subjects and white subjects may result in 
decreased or increased incidence of VZV reactivation, respectively. 
This approach suggests that genetic variations among the human 
race may be behind the propensity toward VZV reactivation. 
One can also argue that the difference in herpes zoster incidence 
between black subjects and white subjects is due to variations of 
the VZV genotypes rather than genetic variations among humans, 
based on the findings of five different clades of VZV, with clade 5 
predominant in Africa and Asia (Quinlivan et al. 2013). This argu-
ment adds credence to Rice’s position that tropical VZV genotypes 
are less prone to reactivation than temperate genotypes. Although 
Figure 5: 
Annual trend of monthly incident cases of herpes zoster and varicella in 2000–2009. Notice that herpes zoster spikes during the warmer months. Source: Wu et 
al. 2013
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Rice writes that immigration from Africa to temperate regions 
gave way to the temperate VZV genotype, such a transition might 
take some time, and recent immigrants and their offspring may 
still harbor the tropical genotype. This is especially plausible when 
taking into account that the reactivating strain of VZV is identi-
cal to the strain that had caused the primary varicella infection 
(Sengupta et al. 2007). Thus, the tropical VZV genotype can persist 
and still be widespread in aging African American populations long 
after immigration from Africa.
Another genetic correlation is suggested Haanpää et al. (2002). 
They suggest that susceptibility to herpes zoster may be geneti-
cally predetermined. Interleukin-10 (IL-10) is an anti-inflammatory 
cytokine; it downregulates the production of the proinflammatory 
cytokines, thus decreasing cell-mediated immunity. The promoter 
region of the gene for IL-10 is polymorphic, producing three dif-
ferent haplotypes (combinations of DNA sequences on one chro-
mosome that are inherited together): GCC, ACC and ATA. Blood 
samples taken from herpes zoster patients and from controls not 
infected with herpes zoster showed a significantly higher pres-
ence of the ATA haplotype in the blood of herpes zoster patients. 
This suggests that IL-10, its presence detected by detection of the 
ATA haplotype, may play a role in VZV reactivation. The explana-
tion of this is that VZV reactivation is largely due to decreased 
cell-mediated immunity, and this immunity is decreased by IL-10. 
Consequently, inheritance of the ATA haplotype may predispose 
one to herpes zoster. This idea is echoed by Cho (2007) who 
writes that in Korea, the GCC haplotype is significantly higher in 
herpes zoster patients than in controls not infected with herpes 
zoster, and this may point to the role of IL-10 in reactivation of 
VZV and a possible genetic predisposition to herpes zoster. Cho 
attributes the differences in increased haplotype findings between 
the previous study conducted in Finland and his own study con-
ducted in Korea simply to ethnic differences between European 
and Asian populations. Their differences notwithstanding, the ideas 
of both studies are the same—that IL-10 may be a factor in VZV 
reactivation leading to herpes zoster, and genetic inheritance of 
a specific haplotype of the IL-10 promoter gene may predispose 
carriers to herpes zoster. This suggestion, too, assumes genetic 
variations in human hosts, rather than genetic variations in the 
VZV itself, to be behind increased or decreased incidence of her-
pes zoster.
Gender Correlation
Numerous studies and trials report a higher incidence of herpes 
zoster in females than in males (Figure 6). In one such report, 
Fleming et al. (2004) investigate the gender differences in inci-
dence of herpes zoster by dividing patients into age groups: 0-14, 
15-24, 25-44, 45-64, 65-74, and 75 and older. Over the eight-year 
study, there were 14,532 cases of herpes zoster, of which 59.3% 
were female patients and 40.7% male patients. Female herpes zos-
ter incidence exceeded males in all age groups except for the 
15-24 age group in which the rates were almost equal for both 
genders. The greatest female risk appeared in the 45-64 age group 
followed by the 0-14 age group.
There are numerous attempts to determine what is behind the fe-
male predisposition to herpes zoster incidence. Possibly, resolving 
what is behind increased female incidence can shed some light on 
the mechanism of VZV reactivation in general.
Various reasons for the female excess are given. One suggestion 
is that there are more herpes zoster cases among females due to 
their longevity; because women live longer than men, there are 
more occasions for them to contract herpes zoster. Fleming et al. 
(2004) write, however, that their analysis disproves the theory, for 
it indicates female excess in nearly all age groups. If increased fe-
male incidence were due to female longevity alone, an increase in 
female incidence would only be evident in older age groups—age 
groups in which females generally outlive males. Another sugges-
tion given is that women tend to seek medical advice more readily 
than men, and, thus, there are more reported cases of females 
with herpes zoster than of males (Thomas and Hall 2004). This 
Figure 6: 
Annual incidence per 100,000 of shingles by age group and gender in years 
1994–2001 with superimposed regression line. Source: Chapman et al. 2003
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would suggest that, in truth, females are not more susceptible to 
herpes zoster than males; it only appears that there is higher her-
pes zoster incidence in females, because they are quicker to see 
a doctor for symptoms, and, thus there are more female herpes 
zoster patients recorded in the system. (In one case, a 60 year 
old man waited ten days before making an appointment to see a 
doctor despite pain rated 6 out of 10 on the pain scale and a rash 
which appeared within a week of the onset of the pain! (Martić 
2014)) This theory, however, would seem to be disproved by the 
data provided by Fleming et al. (2004) which finds that in the age 
group of 15-24, female rates of herpes zoster did not exceed male 
rates and by data provided by Ragozzino et al. (1982) which actu-
ally finds lower incidence of herpes zoster in females aged 35-44 
than in males of the same age group.
A more sophisticated approach to explain the increased herpes 
zoster incidence in females is taken by Fleming et al. (2004). They 
suggest that there may be a true gender difference in the way 
the body responds to reactivation of a latent virus. They base this 
theory on the fact that there is also a significant female excess in 
incidence of herpes simplex virus, another member of the her-
pesvirus family and alphaherpesvirus subclass, which is also a virus 
that reactivates after a long latency period in ganglionic tissue. 
Although they do not specify what might be behind the difference 
in reactivation response based on gender, the suggestion of Studahl 
et al. (2013) may shed some light on it. Studahl et al. suggest that 
the difference in herpes zoster incidence between genders may be 
due to hormonal differences between men and women. It may be 
the hormonal differences between the genders that affect the way 
the body responds to virus reactivation. 
In a similar vein, the menopause transition period females go 
through is also suspected to be responsible for increased female 
herpes zoster incidence due to hormonal changes to their im-
mune response (Saunders 2014). This theory is supported by the 
aforementioned findings of Fleming at al. that females aged 15-24 
did not exceed males in herpes zoster incidence and the findings 
of Ragozzino et al. that females aged 35-44 actually have lower 
herpes zoster incidence than males, for they have not yet reached 
the menopausal stage. This theory, however, fails to address in-
creased herpes zoster incidence in females past the menopausal 
stage, when hormone levels are static.
It should be pointed out that, even according to hypotheses cor-
relating increased herpes zoster incidence in females with their 
hormones or menopausal shifts, they do not claim these to be the 
sole causes of VZV reactivation, for herpes zoster occurs in males 
too, albeit not as prevalent as in females. They simply suggest that 
among other factors influencing VZV activity, these contribute on 
greater levels to its reactivation. Thus, while even those lacking 
these factors may get herpes zoster, those that have these factors 
are at a greater risk of getting herpes zoster.
Still, there does not seem to be a clear understanding as to the 
exact role hormones play in increasing herpes zoster incidence, 
and no explanation has been offered as to which hormones might 
be involved. Are female hormones responsible for the increased 
herpes zoster risk in females, or are male hormones responsible 
for decreased herpes zoster risk in males? After all, males have a 
higher risk for a severe case of chickenpox than females (Simon 
2013). Maybe this points to some type of male hormone influ-
ence on VZV. On the other hand, there is more fluctuation in fe-
male herpes zoster incidence between the different age groups, 
suggesting that female hormones more likely play a role in VZV 
reactivation and that fluctuation in their levels contributes to an 
increase or decrease in herpes zoster incidence. In addition, as 
previously mentioned, the latent VZV is held dormant by cell-me-
diated immunity, not humoral immunity. In pregnant women, “the 
fetoplacental unit redirects maternal immunity away from cell-me-
diated immunity towards enhanced humoral responsiveness” 
(Wegmann et al. 1993). This would lead to the assumption that 
women are at a high risk for VZV reactivation during pregnancy. 
This, however, is not the case. According to Simon (2012), herpes 
zoster is extremely rare in pregnant women. While this phenome-
non is not well understood, it does strengthen the case for female 
hormone involvement in increased female incidence as opposed 
to male hormone involvement in decreased male incidence.
Conclusion
While the particular method of VZV reactivation remains unclear, 
numerous hypotheses are offered based on various presentation 
patterns of herpes zoster. Some suggest that genetics plays a role. 
One such study focuses on regions where herpes zoster is or is 
not prevalent and suggests that VZV genotypes differ according to 
region with temperate genotypes prone to VZV reactivation while 
tropical genotypes are not. Another study focuses on the decreased 
herpes zoster incidence among African Americans and suggests that 
genetic differences between white subjects and subjects of color 
may increase or decrease susceptibility to VZV reactivation. Yet an-
other study suggests that inheritance of certain genetic haplotypes 
may predispose one to herpes zoster. Others focus on the differ-
ence in herpes zoster incidence by gender. Instead of citing genetics 
as possibly influencing increased female incidence, some suggest 
that female hormones may be largely responsible. Similarly, others 
suggest that menopausal instability may prompt VZV reactivation. 
“The peculiar pathogenetic mechanism of herpes zoster infection, 
its capacity to migrate after the primary infection (varicella) to 
the dorsal root ganglia and remain silent throughout life, makes 
it somewhat difficult to put forward convincing hypothetical ex-
planations” (Gallerani and Manfredini 2000). Nonetheless, each of 
these observations of herpes zoster patterns and diverse sugges-
tions as to what is behind the patterns and what they mean sheds 
some light on the mechanism or mechanisms of VZV reactivation. 
Each insight offers a unique angle at which the phenomenon of 
VZV reactivation can be further studied.
65
Varicella Zoster Virus Reactivation
References
[Anonymous]. 2013. Chickenpox. Retrieved from: http://www.
nvic.org/vaccines-and-diseases/chickenpox/chickenpoxfacts.aspx.
[Anonymous]. 2013. Chickenpox Photos. Retrieved from: http://
www.vaccineinformation.org/chickenpox/photos.asp.
[Anonymous]. 2013, July 29. Infant Mortality and African 
Americans. Retrieved from: http://minorityhealth.hhs.gov/tem-
plates/content.aspx?ID=3021.
[Anonymous]. 2014. Shingles Pictures. Retrieved from: http://
www.shinglesinfo.com/shinglesinfo/shingles-in-depth/shingles-pic-
tures.jsp.
Antipuesto DJ. 2008, August 2. Chickenpox vs. Smallpox. 
Retrieved from: http://nursingcrib.com/communicable-diseases/
chickenpox-vs-smallpox/.
Asano Y, Yoshikawa T, Ihira M, Furukawa H, Suzuki K, Suga S. 1999. 
Spread of varicella-zoster virus DNA to family members and en-
vironments from siblings with varicella in a household. Pediatrics 
103(5):e61.
Baird NL, Yu X, Cohrs RJ, Gilden D. 2013. Varicella zoster virus 
(VZV)-human neuron interaction. Viruses 5(9):2106-2115.
Chapman RS, Cross KW, Fleming DM. 2003. The incidence 
of shingles and its implications for vaccination policy. Vaccine 
21(19-20):2541-2547.
Cho JW. 2007. Polymorphism of the IL-10 gene is associat-
ed with susceptibility to herpes zoster in Korea. Journal of 
Dermatological Science 45(3):213-215.
Fleming DM, Cross KW, Cobb WA, Chapman RS. 2004. Gender 
difference in the incidence of shingles. Epidemiology and Infection 
132(1):1-5.
Gallerani M, Manfredini R. 2000. Seasonal variation in herpes 
zoster infection. British Journal of Dermatology 142(3):588-589.
Giménez-Milà M, Busquets C, Ojeda A, Faulí A, Moreno LA, Videla 
S. 2014. Neuropathic pain with features of complex regional 
pain syndrome in the upper extremity after herpes zoster. Pain 
Practice 14(2):158-161.
Haanpää M, Nurmikko T, Hurme M. 2002. Polymorphism of the 
IL-10 gene is associated with susceptibility to herpes zoster. 
Scandinavian Journal of Infectious Diseases 34(2):112-114.
Liesegang TJ. 1999. Varicella zoster viral disease. Mayo Clinic 
Proceedings 74(10):983–998.
Link K. 2005. Chicken pox vaccine. The Vaccine Controversy: The 
History, Use, and Safety of Vaccinations. Westport: Greenwood 
Publishing Group 48.
Martić V. 2014. Recurrent herpes zoster with segmental paresis 
and postherpetic neuralgia. Vojnosanitetski Pregled. Military-
medical and Pharmaceutical Review 71(2):214-217.
Polansky H. 2013, October 1. Study: latent viruses are not 
dormant; new evidence supports microcompetition theory. 
Retrieved from: http://www.prweb.com/releases/2013/10/
prweb11182863.htm.
Quinlivan M, Sengupta N, Papaevangelou V, Sauerbrei A, Grillner L, 
Rousseva R, Hague R, Lutsar I, Jogi P, Leca A, Grytchol R, Alain S, 
Breuer J. 2013. Use of oral fluid to examine the molecular epide-
miology of varicella zoster virus in the United Kingdom and con-
tinental Europe. Journal of Infectious Diseases 207(4):588-593.
Ragozzino MW, Melton LJ3, Kurland LT, Chu CP, Perry HO. 
1982. Population-based study of herpes zoster and its sequelae. 
Medicine (Baltimore) 61(5):310-316.
Raven PH, Johnson GB, Losos J, Singer S. 2005. Answers to Text 
Questions. Retrieved from: https://highered.mcgraw-hill.com/
sites/0072437316/student_view0/chapter56/answers_to_text_
questions.html.
Rice PS. 2011. Ultra-violet radiation is responsible for the differ-
ences in global epidemiology of chickenpox and the evolution 
of varicella-zoster virus as man migrated out of Africa. Virology 
Journal 8(189):
Sampathkumar P, Drage LA, Martin DP. 2009. Herpes zoster 
(shingles) and postherpetic neuralgia. Mayo Clinic Proceedings 
84(3):274-280.
Saunders KM. 2014. Shingles: everything you never thought to ask 
(and how to prevent it). Retrieved from: http://www.menopause.
org/for-women/menopauseflashes/shingles-everything-you-never-
thought-to-ask-(and-how-to-prevent-it).
Schmader K, George LK, Burchett BM, Pieper CF. 1998. Racial 
and psychosocial risk factors for herpes zoster in the elderly. 
Journal of Infectious Diseases 178(Supplement 1):S67-S70.
Sengupta N, Taha Y, Scott FT, Leedham-Green ME, Quinlivan M, 
Breuer J. 2007. Varicella-zoster-virus genotypes in East London: 
a prospective study in patients with herpes zoster. Journal of 
Infectious Diseases 196(7):1014-1020.
Simon H. 2012, May 31. Shingles and chickenpox (Varicella-zoster 
virus). Retrieved from: http://umm.edu/health/medical/reports/
articles/shingles-and-chickenpox-varicellazoster-virus.





Smith MW. 2014, March 7. Slideshow: A Visual Guide 
to Shingles. Retrieved from: http://www.webmd.
com/skin-problems-and-treatments/shingles/ss/
slideshow-shingles-pictures.
Studahl M, Petzold M, Cassel T. 2013. Disease burden of herpes 
zoster in Sweden - predominance in the elderly and in women - 
a register based study. BMC Infectious Diseases 13:586.
Thomas SL, Hall AJ. 2004. What does epidemiology tell us about 
risk factors for herpes zoster? Lancet Infectious Diseases 
4(1):26-33.
Wegmann TG, Lin H, Guilbert L, Mosmann TR. 1993. Bidirectional 
cytokine interactions in the maternal-fetal relationship: is 
successful pregnancy a TH2 phenomenon? Immunology Today 
14(7):353-356.
Wu PY, Wu HDI, Chou TC, Sung FC. 2013. Varicella vaccination 
alters the chronological trends of herpes zoster and varicella. 
PLoS ONE 8(10):1-7.
Zak-Prelich M, Borkowski JL, Alexander F, Norval M. 2002. The 
role of solar ultraviolet irradiation in zoster. Epidemiology and 
Infection 129(3):593-597.
